Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis
NCT07546552
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Female Infertility
NF-κB Ligand
RANKL
Osteoporosis
Follicle Development
Interventions
OTHER:
Denosumab
OTHER:
PBS
Sponsor
Peter Humaidan
Collaborators
[object Object]